A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Clinical trial NCT00234429 · COMPLETED

Trial details

NCT number: NCT00234429
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2003-11-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.